BRIEF published on 04/24/2026 at 07:05, 1 month 9 days ago BB Biotech AG Reports Q1 2026 Interim Results Drug Development Net Loss Investment Portfolio BB Biotech Q1 2026
BRIEF published on 04/24/2026 at 07:05, 1 month 9 days ago BB Biotech Q1 2026 Achievements and Strategic Shifts Net Asset Value Portfolio Repositioning New Investments BB Biotech Performance Dividend Inclusion
PRESS RELEASE published on 04/24/2026 at 07:00, 1 month 9 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first quarter of 2026, showing a net loss of CHF 21 mn compared to CHF 241 mn in the same period of 2025 Investment Company BB Biotech AG Interim Report Results Loss
PRESS RELEASE published on 04/24/2026 at 07:00, 1 month 9 days ago BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning BB Biotech AG reports Q1 2026 results with share price outperformance, narrowing discount, and active portfolio repositioning. Eleven new investments made in biotech sector Share Price BB Biotech AG Investments Portfolio Repositioning Q1 2026
BRIEF published on 03/19/2026 at 17:45, 2 months 14 days ago BB Biotech AG's AGM Approves Proposals and Dividend Annual General Meeting Investment Strategy Board Re-election Dividend Approval BB Biotech
PRESS RELEASE published on 03/19/2026 at 17:40, 2 months 14 days ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.25 per share Shareholders at BB Biotech AG's AGM approve CHF 2.25 dividend per share. Board proposals endorsed. Re-election of board members Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/20/2026 at 07:05, 3 months 11 days ago BB Biotech AG Releases 2025 Annual Report Dividend Proposal Biotechnology Sector Net Profit Increase BB Biotech 2025 Annual Report
BRIEF published on 02/20/2026 at 07:05, 3 months 11 days ago BB Biotech's 2025 Annual Report Highlights Strong Financial Gains Annual Report Portfolio Value Shareholder Returns BB Biotech Financial Gains
PRESS RELEASE published on 02/20/2026 at 07:00, 3 months 11 days ago EQS-Adhoc: BB Biotech AG publishes its 2025 annual report BB Biotech AG releases its 2025 annual report, reporting a strong performance with a +34.2% total return in CHF. The annual report includes detailed information on the biotechnology sector and the company's investments Financial Results Investment BB Biotech AG Biotechnology Sector 2025 Annual Report
PRESS RELEASE published on 02/20/2026 at 07:00, 3 months 11 days ago Annual Report 2025: BB Biotech delivers strong performance and portfolio value realization BB Biotech AG's Annual Report 2025 showcases strong performance and portfolio value realization. Shareholder returns, active capital management, and refined investment processes highlighted BB Biotech AG Portfolio Value Shareholder Returns Annual Report 2025 Investment Processes
Published on 06/03/2026 at 04:58, 3 hours 39 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 8 hours 37 minutes ago Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/02/2026 at 22:30, 10 hours 7 minutes ago INEO Announces Effective Date of Share Consolidation
Published on 06/02/2026 at 19:45, 12 hours 52 minutes ago Announces Plans to Repurchase Common Shares
Published on 06/03/2026 at 08:00, 37 minutes ago Aquis Stock Exchange: Application for Admission Announcement
Published on 06/03/2026 at 07:35, 1 hour 1 minute ago Factorial Raises $150M Series D, Reaches $2.5 Billion Valuation to Become One of the Most Valuable AI Scale-Ups in Europe
Published on 06/03/2026 at 07:30, 1 hour 7 minutes ago voestalpine AG: voestalpine increases earnings despite a volatile environment in the 2025/26 business year
Published on 06/03/2026 at 07:30, 1 hour 7 minutes ago Deutsche Rohstoff AG: 2026 development on track– first pad delivers strong initial production
Published on 06/03/2026 at 07:05, 1 hour 31 minutes ago National Bank of Georgia Launches Modernized RTGS Payment System with Montran
Published on 06/02/2026 at 18:03, 14 hours 33 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 14 hours 55 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 14 hours 57 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 1 day 1 hour ago OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest
